Intellectual Property India Publishes Patent Application for Istaroxime And Metabolite Derivatives Thereof For Reducing The Risk Of Acute Myocardial Arrhythmia

MUMBAI, India, Aug. 24 -- Intellectual Property India has published a patent application (202517016796 A) filed by Windtree Therapeutics, Inc. on February 26, 2025, for Istaroxime And Metabolite Derivatives Thereof For Reducing The Risk Of Acute Myocardial Arrhythmia.

Inventors include Simonson, Steven; and Hsu, Shih-Che.

The application for the patent was published on August 21, 2026, under issue no. 34/2026.

Abstract: Compositions for intravenous infusion of istaroxime or derivatives thereof in human patients suffering from AHF with acute myocardial ischemia and/or an acute myocardial infarction are disclosed. The patient may optionally be in early cardiogenic or cardiogenic shock. Likewise, methods of administering istaroxime or deriv...